Characterizing ProstivaTM RF Treatments of the Prostate for BPH with Gadolinium-Enhanced MRI
Transurethral needle ablation (TUNA) is an accepted and effective therapy for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). ProstivaTM (Medtronic, Shoreview, MN) is the newest-generation device, which includes a new needle design and radio frequency...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2009-01-01
|
| Series: | The Scientific World Journal |
| Online Access: | http://dx.doi.org/10.1100/tsw.2009.4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832567851044569088 |
|---|---|
| author | Christian Huidobro Benjamin Larson Samuel Mynderse James J. Myers David Busel Cristian Acevedo Thayne R. Larson Lance A. Mynderse |
| author_facet | Christian Huidobro Benjamin Larson Samuel Mynderse James J. Myers David Busel Cristian Acevedo Thayne R. Larson Lance A. Mynderse |
| author_sort | Christian Huidobro |
| collection | DOAJ |
| description | Transurethral needle ablation (TUNA) is an accepted and effective therapy for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). ProstivaTM (Medtronic, Shoreview, MN) is the newest-generation device, which includes a new needle design and radio frequency (RF) generator. This device creates temperatures of 120°C and necrotic lesions in less than 2.5 min. Using previously described techniques, we analyzed dynamic, gadolinium-enhanced MRIs to characterize the ablative properties of the new ProstivaTM RF device. |
| format | Article |
| id | doaj-art-2cd92386cc25442fb322da5ac1db76ea |
| institution | Kabale University |
| issn | 1537-744X |
| language | English |
| publishDate | 2009-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | The Scientific World Journal |
| spelling | doaj-art-2cd92386cc25442fb322da5ac1db76ea2025-02-03T01:00:23ZengWileyThe Scientific World Journal1537-744X2009-01-019101610.1100/tsw.2009.4Characterizing ProstivaTM RF Treatments of the Prostate for BPH with Gadolinium-Enhanced MRIChristian HuidobroBenjamin LarsonSamuel MynderseJames J. MyersDavid BuselCristian AcevedoThayne R. LarsonLance A. MynderseTransurethral needle ablation (TUNA) is an accepted and effective therapy for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). ProstivaTM (Medtronic, Shoreview, MN) is the newest-generation device, which includes a new needle design and radio frequency (RF) generator. This device creates temperatures of 120°C and necrotic lesions in less than 2.5 min. Using previously described techniques, we analyzed dynamic, gadolinium-enhanced MRIs to characterize the ablative properties of the new ProstivaTM RF device.http://dx.doi.org/10.1100/tsw.2009.4 |
| spellingShingle | Christian Huidobro Benjamin Larson Samuel Mynderse James J. Myers David Busel Cristian Acevedo Thayne R. Larson Lance A. Mynderse Characterizing ProstivaTM RF Treatments of the Prostate for BPH with Gadolinium-Enhanced MRI The Scientific World Journal |
| title | Characterizing ProstivaTM RF Treatments of the Prostate for BPH with Gadolinium-Enhanced MRI |
| title_full | Characterizing ProstivaTM RF Treatments of the Prostate for BPH with Gadolinium-Enhanced MRI |
| title_fullStr | Characterizing ProstivaTM RF Treatments of the Prostate for BPH with Gadolinium-Enhanced MRI |
| title_full_unstemmed | Characterizing ProstivaTM RF Treatments of the Prostate for BPH with Gadolinium-Enhanced MRI |
| title_short | Characterizing ProstivaTM RF Treatments of the Prostate for BPH with Gadolinium-Enhanced MRI |
| title_sort | characterizing prostivatm rf treatments of the prostate for bph with gadolinium enhanced mri |
| url | http://dx.doi.org/10.1100/tsw.2009.4 |
| work_keys_str_mv | AT christianhuidobro characterizingprostivatmrftreatmentsoftheprostateforbphwithgadoliniumenhancedmri AT benjaminlarson characterizingprostivatmrftreatmentsoftheprostateforbphwithgadoliniumenhancedmri AT samuelmynderse characterizingprostivatmrftreatmentsoftheprostateforbphwithgadoliniumenhancedmri AT jamesjmyers characterizingprostivatmrftreatmentsoftheprostateforbphwithgadoliniumenhancedmri AT davidbusel characterizingprostivatmrftreatmentsoftheprostateforbphwithgadoliniumenhancedmri AT cristianacevedo characterizingprostivatmrftreatmentsoftheprostateforbphwithgadoliniumenhancedmri AT thaynerlarson characterizingprostivatmrftreatmentsoftheprostateforbphwithgadoliniumenhancedmri AT lanceamynderse characterizingprostivatmrftreatmentsoftheprostateforbphwithgadoliniumenhancedmri |